Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings from University of Texas, U.S., in the area of breast cancer detailed
August 27th, 2007
Data on breast cancer are outlined in reports from University of Texas, U.S. Study 1: Researchers detail in "Phase II trial of 10-EDAM in the treatment of metastatic breast cancer," new data in breast cancer. According to a study from the United States, "This phase II trial was conducted to assess the efficacy and safety of 10-Ethyl-10-Deaza-Aminopterin (10-EDAM), a folate antagonist, in metastatic breast cancer patients who had received no more than one prior chemotherapy regimen. Fifty-five patients were treated on an initial weekly dose 80 mg/m2 of 10-EDAM." "Patients who had received a prior chemotherapy regimen in the adjuvant setting...
Source: Clinical Trials Week (2007-08-27)
|
